ArriVent BioPharma, Inc. AVBP Cash Flow Statement
| FY'25 | FY'24 | ||
|---|---|---|---|
| -$166.31M-107% | -$80.49M-16.1% | ||
| -$3.03M— | —— | ||
| $12.52M+290% | $3.21M+258% | ||
| -$160.59M-129% | -$70.21M-25.7% | ||
| -$71.23M+63.0% | -$192.47M— | ||
| $203.06M+8.8% | $186.58M— | ||
| -$28.75M— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does ArriVent BioPharma, Inc.'s cash flow data come from?
- Every line is extracted from ArriVent BioPharma, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.